FDA approves first coronavirus drug, may help recovery

The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

This entry was posted in Main. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *